How life sciences companies are measuring their ESG impact

EY Health Sciences & Wellness podcast series

In this episode, Barend van Bergen, EY Global Long-term Value Methodology Leader and Sonja Haut, Head of Impact Valuation for Novartis discuss how companies are measuring their ESG impact. Together they review the growing importance of sustainable health solutions, ESG in healthcare and sustainability reporting in the Health Sciences and Wellness industry. Learn how ESG reporting and the information flow that helps businesses successfully engage with their stakeholders. The conversation also explores global use cases, the significance of banking for impact, and the gaps in impact measurement that need attention in the coming years. Uncover the multitude of metrics available in sustainability reporting, the growing importance of sustainability metrics, and their potential to drive transformative conversations.